The price trend for Nuwellis, Inc. (NUWE) has been bearish lately and the stock has lost 18.7% over the past week. However, the formation of a hammer chart pattern in its last trading session ...
(Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, announced today that a leading Northeastern U.S. children’s hospital has ...
Nuwellis announced Friday that the first pediatric patient has been treated with the newly launched Quelimmune therapy. Roth MKM analyst Jonathan Aschoff initiates coverage on Nuwellis with a Buy ...
Nuwellis (NUWE) announced that a Northeastern U.S. children’s hospital has initiated an Aquadex Ultrafiltration Program. Pediatric nephrology and ...
The FDA is addressing a potentially high-risk issue linked to certain lots of the AquaFlexFlow UF 500 Plus extracorporeal blood circuit, a device produced by Nuwellis Inc (NASDAQ:NUWE). The device, ...
MINNEAPOLIS, March 11, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company focused on transforming the lives of people with fluid overload, today reported ...
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback